{"name":"Verity Pharmaceuticals Inc.","slug":"verity-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Bacillus Calmette-Guerin: Strain TICE","genericName":"Bacillus Calmette-Guerin: Strain TICE","slug":"bacillus-calmette-guerin-strain-tice","indication":"Non-muscle invasive bladder cancer (NMIBC)","status":"phase_3"}]}],"pipeline":[{"name":"Bacillus Calmette-Guerin: Strain TICE","genericName":"Bacillus Calmette-Guerin: Strain TICE","slug":"bacillus-calmette-guerin-strain-tice","phase":"phase_3","mechanism":"BCG TICE is a live attenuated mycobacterial vaccine that stimulates innate and adaptive immune responses to enhance anti-tumor immunity.","indications":["Non-muscle invasive bladder cancer (NMIBC)","Potentially other solid tumors (investigational)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPUi1PZTA4RnhTUU1RUmRITlpoZGZCaFp6ZEZEYS1HdTQ5V1pWUFNIWC1LVWpYaDRfRWxHRkE0RGNXcDhOUUN4NHY0bXV3dUdNOWoyMGoyZzJxbEszdFF1Zm9Jc2QxeHR0OHR6djBNeHRnTWZ4VmNTWms1dUNCRDFXRkdudEpaZ240ZVR0TG05eW1URS0wdzI4Um9pMDIzTU9pQWJIRklodUY0MGh6NGNlanZ3dXUzdjNsN0hDU0JpUU8yS1V2RV9IWGtJVEhfRVMtQXp1TVB0SFgyLU1hVnE4UjJYcVV3MmcyNV9sQUMxVUg1TTNadkN0Tzl1anN1aVgtY3dXLWQtam1kMXRoQS1XVlVLMUhjUQ?oc=5","date":"2026-03-25","type":"trial","source":"Barchart.com","summary":"Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering N","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPUWRsVlFKWGJSNTlzaFpub25UQ3JySkZwcGtvRGNMM2htSzR0RW1Eek5WRl9xMUpzQnlDa2ROT0cyUk5ZSTRXSTNQcjUxd2Z2T2pkZm04LWNidExyTm9SR2ZoYkdBUlcwLS1wUXpwREtXVkd6ZWdpN2FmSVhpa0NUaTVtVlh0MDhtWVNPdEpxU3UwMllPR1lDTUdB?oc=5","date":"2026-03-25","type":"trial","source":"openPR.com","summary":"Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline - openPR.com","headline":"Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNUUtWbUhmdDM3SjRSeXI5dnZzVUtmeEI0cGJpWXI2SkxOSDNWU3VUODZNWElDWnh2eGlNNTR4emlNV1Nnd21jN28zWWNoaXhaYzJIdS1kOWR0LWl6cUJuN2JGTTR6YncwU2xzZmlTelgzTndjR3VfdjhXcGh2UE80MUhOVFVhUGVTZ05qdVRsa2FvRnQ1ZmVwRWNGMXpIcmVMV1AxVHZOeUlIajBvYnY0?oc=5","date":"2025-10-23","type":"pipeline","source":"Nasdaq","summary":"Investment Firm Verity & Verity Loads Up With 908,000 Pfizer (PFE) Shares Worth $22.4 Million - Nasdaq","headline":"Investment Firm Verity & Verity Loads Up With 908,000 Pfizer (PFE) Shares Worth $22.4 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxOaG1BQ0JaNDZKNzNCNS1tM2JpZUhXVjZBTGR6d2k3UHZYZjRQMUw5UlNKb2tLOGtOdlpMQ2JuQ2MwRHVHN1Y5ZXN3TTFRWHpVVmlaNXVTbXVDMGhGc0FVZjdGODFZMV8wVWlEUG52Yzc4eE05UWRfYWd2cFI3ZGZQSUxiYzBvWGpXalVFZzR3M3ZqR3N2dkw2Vnh5MWgwdS1qNndRNUU1QUg5cW9HVjlfYjZVX0hyaER0dDI4TDh1eDdkWmduVlZxUHVUU2xwSHBUdzNXeUF6Wjg5d3RlS2Y1X1hrd2Fla1l1Z0xtaHV1MlR6bFVETkFpdUt5X2EtaV8yRnBkdlFndHNpdkx6THY1VVlueFJDYjJQNG40R2hhZEE?oc=5","date":"2025-10-20","type":"deal","source":"PR Newswire","summary":"HealthVerity and Claritas Rx announce strategic partnership to unlock more actionable real-world insights for commercial, RWE, and HEOR teams - PR Newswire","headline":"HealthVerity and Claritas Rx announce strategic partnership to unlock more actionable real-world insights for commercial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNQkxHXzl3T2lJQUMzRUdQdFZraDctTF9ZZXRqc0hYMWttQzdQbV9xeUYxYWZmZjAzMFh4T2w3aTlBUjV2eHJNejJkcHFxYlRYbjBRc3E1MjNpVlAtTmxoMFNpaWY0d1NxRjJleldKZmc2VGpIMFBTZUVtU0s2clpFS21aejJZUWFOMHhUbExsSGRNZm5hOHhkcTBabms0VFlZUmlwY0VrR05WYVpwRklGRmN6SlFxZ0xW?oc=5","date":"2025-06-09","type":"regulatory","source":"Stock Titan","summary":"Groundbreaking Oral Testosterone Treatment Eyes 700,000-Strong Canadian Market After FDA Success - Stock Titan","headline":"Groundbreaking Oral Testosterone Treatment Eyes 700,000-Strong Canadian Market After FDA Success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxQU2ttSnRmbldsOGVmanczUS1OZlI3T2l5RjJlZ3M5M211NGc2MnBiWVNXaU9ndkVfYjk5VWc3amR3NlFyekNqOV9OM3RNUWdCV2dkaHhKa0RMcjVGZHNUMXRJRDFveEJuUGhtYUxzcjRXYi1ELVVXLXJyNTBwNHBWVG50MGdMajFzWU1kWjFPdkZhVTc5S3A4WlR3d0dwZ09KMERuWVlLRllNemlHRk4wa3NfMjBWRlNrRUF3WjM4WEk1MHJaeDFIWF9Pel83QUNQMHkyaWZNeThKQW5iOG92SWlDR2NDWWZLeWFQYnJIdUU0TmM?oc=5","date":"2025-02-19","type":"pipeline","source":"Pharmacy Times","summary":"Advancements in the Management of Nonmetastatic Castrate-Resistant Prostate Cancer: A Review of Second-Generation Antiandrogens - Pharmacy Times","headline":"Advancements in the Management of Nonmetastatic Castrate-Resistant Prostate Cancer: A Review of Second-Generation Antian","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNNjg0LVNMZVM1eWJJTE9kdWhTeU9aa3QtbnVhaVk5WWpJU1FheU90SVdySU8zZkNwYjNodWhfVndDOFNSRXNlMWFOZ2oweVlWcFlGVFF0SXVyYXZHUGE3Y2prczZReS10MlNrTlJDWVE0bWg5U3NFcVVhS1FyYVFuX1hNdHZRbWpuMFh3aEp0MDJWS0xmUWZnOXRselFhOVUtbWxORlhZQ0tqR1ppX21PbkFDYU5uSTRLTElBX01Bd29HVGh3akE5d1IzTG9wU0ppYXlQVjR3OGUyeWlqTU9TaDV2WW1wZVY4?oc=5","date":"2024-01-18","type":"deal","source":"PR Newswire","summary":"Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada - PR Newswire","headline":"Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxQUElZeTNFSVFHakthV0xsVkNXR2tkazFoT3JrVk83dFhOWTh5NTY3ZERHZVRrV1dobEFlemtxdUN0U1ZGd3M2Z1V2Vm1VS1lweUM0bkRPQXlINlpPekNLaVJwN2ZUWUVxc1l4bm9JOExqZkx0ckVEdk9TZ2xMYTg1QWN3YnQ2NzJGcERQeDRUNWtjbXlQVXNjT2dvSzdibkZyRjhKbDl6anNTNDI4Zm5YMndwN3YwX3JhclU2UFp1T2dib0IwaDdZQWxqV2FUWUJzQUFIMm5ld3RqekFEY09XRlNpMWNtZXl2ajdjaDQyZDA4SENiYU9URldtQVlKck9yY1BhOE5aQ3k?oc=5","date":"2022-05-09","type":"pipeline","source":"PR Newswire","summary":"Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand Support for Sancuso® - PR Newswire","headline":"Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand Support for Sancus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOUFdUOUZlbXJ3VnI3dkVMdVpUSV9VOEhONm9jSTIyYXQySnJlOURKMjBsLXdfZ2doVEZNU2xGb0J1UDdHM3UxNlhkZkI3NzlraHBCS3VCN2ZrenM5Ym8tcW1yMDNQckFwX01rNS0xaUR4Q2R4RTBuYjR5a1dMNzJUZVRrSExNS0dzM0lyT3QxQ014dXpDWVhLbHBzdHNmRUQ4WW4tbm5SSEhQeTdOTmIyMkh5OFdWRjFnbEtOcWhqS1NaVTNTX3U0N3RFZDlIQUZaMDZwY25VOVd0U2N6c0FkeWVqdHFHcXVYeUxNT21DZlpIb0s2U21z?oc=5","date":"2021-03-08","type":"trial","source":"Amazon Web Services","summary":"Executive Conversations: Modernizing the approach to healthcare data with Andrew Goldberg, Co-founder and COO of HealthVerity - Amazon Web Services","headline":"Executive Conversations: Modernizing the approach to healthcare data with Andrew Goldberg, Co-founder and COO of HealthV","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-02-27","type":"regulatory","source":"The Economic Times","summary":"Serum Institute of India receives Health Canada approval to supply vaccines to Canada - The Economic Times","headline":"Serum Institute of India receives Health Canada approval to supply vaccines to Canada","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNZjh2SzN1eEFYRENlZlZIVUhiM2JyTnE3NUFTXzFuYlBhNDMtaS1iV2dkUGpWZFlJU3lGUnVyYTBERUJTVlVGUGZqa1haNjIyLTFaeVpiS2lKX2FKOVNoazVGUHA4MkJRRlJyU1NVX1VWVTF5MmZUMHd3c196M19LbXN3NGZZbVhNUnItQnVTdWtaZw?oc=5","date":"2020-11-04","type":"pipeline","source":"Urology Times","summary":"The BCG shortage: What's being done—and what you can do - Urology Times","headline":"The BCG shortage: What's being done—and what you can do","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQNllnUGNmS0NHX0s2VG5FbTJPaU82MWhNZWcyalpwekJraTVLSS1fcDE4SUpwaENiLWhKZjBKdDBEUkgzTVp6c3JZb2w0enpDMFFqSURocmItNVNZalU4T1FLSUQ1VXBIX3Y5VENyeHpEWVRlTmVMcFZEajdVYXBta0ZUT3JRLXl6WVJ6eklQSG4yQUlRUktrdXp3QWhSejV3TTVfZF9mdVZUYUxqSmhmdmFtLUluTkc0M3dKSVVUdnBzZTJDWDV5LTNFejBzTm5BSkZ4SklB?oc=5","date":"2020-02-25","type":"pipeline","source":"GlobeNewswire","summary":"Point Biopharma Launches With Radiopharmaceutical Development Focus - GlobeNewswire","headline":"Point Biopharma Launches With Radiopharmaceutical Development Focus","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}